Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A powerful drug combination strategy targeting glutamine addiction for the treatment of human liver cancer
Haojie Jin, Siying Wang, Esther A. Zaal, et al.
eLife (2020) Vol. 9
Open Access | Times Cited: 137

Showing 1-25 of 137 citing articles:

Targeting cancer metabolism in the era of precision oncology
Zachary E. Stine, Zachary T. Schug, Joseph M. Salvino, et al.
Nature Reviews Drug Discovery (2021) Vol. 21, Iss. 2, pp. 141-162
Open Access | Times Cited: 751
The immunological and metabolic landscape in primary and metastatic liver cancer
Xin Li, Pierluigi Ramadori, Dominik Pfister, et al.
Nature reviews. Cancer (2021) Vol. 21, Iss. 9, pp. 541-557
Closed Access | Times Cited: 396
Metabolic dysregulation and emerging therapeutical targets for hepatocellular carcinoma
Danyu Du, Chan Liu, Mengyao Qin, et al.
Acta Pharmaceutica Sinica B (2021) Vol. 12, Iss. 2, pp. 558-580
Open Access | Times Cited: 365
The Role of PI3K/AKT/mTOR Signaling in Hepatocellular Carcinoma Metabolism
Lingyu Tian, Daniel J. Smit, Manfred Jücker
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2652-2652
Open Access | Times Cited: 123
Amino acid metabolism, transport and signalling in the liver revisited
Coen C. Paulusma, Wouter H. Lamers, Stefan Bröer, et al.
Biochemical Pharmacology (2022) Vol. 201, pp. 115074-115074
Open Access | Times Cited: 86
Metabolic reprogramming and its clinical implication for liver cancer
Flora Yang, Leena Hilakivi‐Clarke, Aurpita Shaha, et al.
Hepatology (2023) Vol. 78, Iss. 5, pp. 1602-1624
Open Access | Times Cited: 63
The pleiotropic functions of reactive oxygen species in cancer
Katherine Wu, Ahmed E. El Zowalaty, Volkan I. Sayin, et al.
Nature Cancer (2024) Vol. 5, Iss. 3, pp. 384-399
Closed Access | Times Cited: 58
Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54
Cancer metabolism and carcinogenesis
Jianqiang Yang, Chloe Shay, Nabil F. Saba, et al.
Experimental Hematology and Oncology (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 33
Mitochondrial-cytochrome c oxidase II promotes glutaminolysis to sustain tumor cell survival upon glucose deprivation
Yong Yi, Guoqiang Wang, Wenhua Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 3
Glutathione and its precursors in cancer
Gloria Asantewaa, Isaac S. Harris
Current Opinion in Biotechnology (2021) Vol. 68, pp. 292-299
Closed Access | Times Cited: 88
Advancing Cancer Treatment by Targeting Glutamine Metabolism—A Roadmap
Anna Halama, Karsten Suhre
Cancers (2022) Vol. 14, Iss. 3, pp. 553-553
Open Access | Times Cited: 61
Mitochondrial and metabolic alterations in cancer cells
Jacopo Di Gregorio, Sabrina Petricca, Roberto Iorio, et al.
European Journal of Cell Biology (2022) Vol. 101, Iss. 3, pp. 151225-151225
Open Access | Times Cited: 45
SLC1A5 enhances malignant phenotypes through modulating ferroptosis status and immune microenvironment in glioma
Liying Han, Jinpeng Zhou, Leiyang Li, et al.
Cell Death and Disease (2022) Vol. 13, Iss. 12
Open Access | Times Cited: 45
Metabolomics-assisted discovery of a new anticancer GLS-1 inhibitor chemotype from a nortopsentin-inspired library: From phenotype screening to target identification
Daniela Carbone, Vincenzo Vestuto, Maria Rosalia Ferraro, et al.
European Journal of Medicinal Chemistry (2022) Vol. 234, pp. 114233-114233
Closed Access | Times Cited: 41
Metabolism as a New Avenue for Hepatocellular Carcinoma Therapy
Davide Gnocchi, Carlo Sabbà, Mara Massimi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 4, pp. 3710-3710
Open Access | Times Cited: 25
Activation of polyamine catabolism promotes glutamine metabolism and creates a targetable vulnerability in lung cancer
Xinlu Han, Deyu Wang, Yang Liao, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 13
Open Access | Times Cited: 15
Unrestricted molecular motions enable mild photothermy for recurrence-resistant FLASH antitumor radiotherapy
Hanchen Shen, Hongbin Wang, Jianlan Mo, et al.
Bioactive Materials (2024) Vol. 37, pp. 299-312
Open Access | Times Cited: 12
Targeting glutamine metabolism exhibits anti-tumor effects in thyroid cancer
Guo‐Qiang Zhang, Xi Chen, Ning Ju, et al.
Journal of Endocrinological Investigation (2024) Vol. 47, Iss. 8, pp. 1953-1969
Open Access | Times Cited: 8
DYRK1A-TGF-β signaling axis determines sensitivity to OXPHOS inhibition in hepatocellular carcinoma
Ying Cao, Ruolan Qian, Ruiqin Yao, et al.
Developmental Cell (2025)
Closed Access | Times Cited: 1
Interactions between the metabolic reprogramming of liver cancer and tumor microenvironment
Haoqiang Yang, Jinghui Li, Yuanjie Niu, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access | Times Cited: 1
Ionizing Radiation Upregulates Glutamine Metabolism and Induces Cell Death via Accumulation of Reactive Oxygen Species
Pengfei Yang, Xiangxia Luo, Jin Li, et al.
Oxidative Medicine and Cellular Longevity (2021) Vol. 2021, Iss. 1
Open Access | Times Cited: 48
Ganoderma lucidum Spore Polysaccharide Inhibits the Growth of Hepatocellular Carcinoma Cells by Altering Macrophage Polarity and Induction of Apoptosis
Ming Song, Zhenhao Li, Hong-Shun Gu, et al.
Journal of Immunology Research (2021) Vol. 2021, pp. 1-14
Open Access | Times Cited: 46
Host cell glutamine metabolism as a potential antiviral target
Sandro Massao Hirabara, Renata Gorjão, Adriana Cristina Levada‐Pires, et al.
Clinical Science (2021) Vol. 135, Iss. 2, pp. 305-325
Closed Access | Times Cited: 42
GOT2 Silencing Promotes Reprogramming of Glutamine Metabolism and Sensitizes Hepatocellular Carcinoma to Glutaminase Inhibitors
Yunzheng Li, Binghua Li, Yanchao Xu, et al.
Cancer Research (2022) Vol. 82, Iss. 18, pp. 3223-3235
Open Access | Times Cited: 37
Page 1 - Next Page

Scroll to top